Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer
Sommerhäuser, G, Kurreck, A, Stintzing, S, Heinemann, V, von Weikersthal, L. Fischer, Dechow, T, Kaiser, F, Karthaus, M, Schwaner, I, Fuchs, M, König, A, Roderburg, C, Hoyer, I, Quante, M, Kiani, A, Fruehauf, S, Müller, L, Reinacher-Schick, A, Ettrich, T. J, Stahler, A, Modest, D. P
Published in BMC cancer (27.07.2022)
Published in BMC cancer (27.07.2022)
Get full text
Journal Article
Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)
Kurreck, A., Geissler, M., Martens, U. M., Riera-Knorrenschild, J., Greeve, J., Florschütz, A., Wessendorf, S., Ettrich, T., Kanzler, S., Nörenberg, D., Seidensticker, M., Held, S., Buechner-Steudel, P., Atzpodien, J., Heinemann, V., Stintzing, S., Seufferlein, T., Tannapfel, A., Reinacher-Schick, A. C., Modest, D. P.
Published in Journal of cancer research and clinical oncology (01.10.2020)
Published in Journal of cancer research and clinical oncology (01.10.2020)
Get full text
Journal Article
Dermatology-related quality-of-life outcomes in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab (Pmab) maintenance after FOLFOX + Pmab induction: a prespecified secondary analysis of the phase II randomized PanaMa (AIO KRK 0212) trial
Ballhausen, A., Karthaus, M., Fruehauf, S., Graeven, U., Müller, L., König, A.O., von Weikersthal, L.F., Sommerhäuser, G., Jelas, I., Alig, A.H.S., Kurreck, A., Stahler, A., Goekkurt, E., Held, S., Kasper, S., Heinrich, K., Heinemann, V., Stintzing, S., Trarbach, T., Modest, D.P.
Published in ESMO open (01.07.2024)
Published in ESMO open (01.07.2024)
Get full text
Journal Article
Impact of sex on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC). Subgroup analysis of the PanaMa-study (AIO-KRK-0212)
Heinrich, K., Karthaus, M., Fruehauf, S., Graeven, U., Mueller, L., König, A.O., von Weikersthal, L. Fischer, Caca, K., Kretzschmar, A., Goekkurt, E., Haas, S., Alig, A.H.S., Kurreck, A., Stahler, A., Held, S., Sommerhäuser, G., Heinemann, V., Stintzing, S., Trarbach, T., Modest, D.P.
Published in ESMO open (01.08.2023)
Published in ESMO open (01.08.2023)
Get full text
Journal Article
1301P Sequential therapy of metastatic pancreatic ductal adenocarcinoma (PDAC) after failure of gemcitabine plus nab-paclitaxel with either 5-FU/folinic acid (5FU/LV) plus irinotecan (FOLFIRI) followed by 5FU/LV plus oxaliplatin (OFF) or the reverse sequence: The PANTHEON trial (AIO PAK 0116)
Modest, D.P., Heinemann, V., Schütt, P., Angermeier, S., Haberkorn, M., Waidmann, O., Graeven, U., Wille, K., Kunzmann, V., Henze, L., Constantin, C., De Wit, M., Denzlinger, C., Kurreck, A., Alig, A.H.S., Stahler, A., Pelzer, U., Stintzing, S., Oettle, H.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
443TiP Impact of a centralized tumour board on secondary intervention rate in patients with RAS mutant metastatic colorectal cancer after first-line treatment with FOLFOXIRI plus bevacizumab (FIRE-7, AIO-KRK-0120)
Stahler, A., Heinrich, K., Stintzing, S., Jelas, I., Pratschke, J., Schöning, W., Angele, M., D'Haese, J., Gebauer, B., Seidensticker, M., Streitparth, F., Kunz, W.G., Corradini, S.D., Stromberger, C., Vehling-Kaiser, U., Zhang, D., Kurreck, A., Alig, A.H.S., Modest, D.P., Heinemann, V.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
621P The systemic proteome of consensus molecular subtypes from patients with RAS wild-type metastatic colorectal cancer: Analysis from the randomized phase II PanaMa (AIO KRK0212) trial
Ballhausen, A., Shomroni, O., Stahler, A., Hoppe, B., Karthaus, M., Fruehauf, S., Graeven, U., Sommerhäuser, G.M., Alig, A.H.S., Goekkurt, E., Meyer-Knees, J., Kurreck, A., Held, S., Kasper-Virchow, S., Heinemann, V., Stintzing, S., Trarbach, T., Mülleder, M., Ralser, M., Modest, D.P.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
396P Impact of depth of response of induction therapy on consecutive maintenance therapy in patients with RAS wild-type metastatic colorectal cancer: An analysis of the PanaMa trial (AIO KRK 0212)
Sommerhäuser, G.M., Kurreck, A., Fehrenbach, U., Beck, A., Karthaus, M., Fruehauf, S., Graeven, U., Müller, L., Koenig, A.O., Fischer von Weikersthal, L., Goekkurt, E., Haas, S., Stahler, A., Heinemann, V., Held, S., Alig, A.H.S., Kasper, S., Stintzing, S., Trarbach, T., Modest, D.P.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
변형된 핵산 접합체
FECHLER BITTETI MONA, SHAEF IDA, KURRECK JENS, HILLER THOMAS, FUCHS MERLE
Year of Publication 01.09.2023
Get full text
Year of Publication 01.09.2023
Patent